Last reviewed · How we verify
cycle 1: reference drug
At a glance
| Generic name | cycle 1: reference drug |
|---|---|
| Sponsor | Shenzhen TargetRx Co., Ltd. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- cycle 1: reference drug CI brief — competitive landscape report
- cycle 1: reference drug updates RSS · CI watch RSS
- Shenzhen TargetRx Co., Ltd. portfolio CI